Presbyopia Treatment Market Size, Share & Trend | Industry Analysis Report, 2026

Posted by Aniket Ankushrao on May 23rd, 2019

Presbyopia is an age-related blurring of close-up vision, wherein near vision becomes blurred, making it hard to focus while doing things such as reading material such as books, magazines, menus, labels, using smartphone, or working on the computer. Presbyopia is one of the most common eye disorders across the world and is common among the geriatric population. Presbyopia occurs over a long period of time and is initially asymptomatic or causes only a slight decrease in vision. However, over time, this becomes quite marked. Presbyopia disorders cannot currently be cured, and the treatment is aimed at managing the vision in order to reduce the severity of symptoms and slow progression.

Prevalence of presbyopia is higher in the elderly population. With the increase in aging population, unprecedented numbers of patients with presbyopia can be expected to present to optometrists offices in the coming years for the diagnosis of presbyopia. Presbyopia is age related and its prevalence is directly related to the proportion of elderly people in the population. However, it is difficult to estimate the incidence of a chronic condition such as presbyopia due to its slow onset. Incidence of presbyopia is the highest in persons aged 42 to 44. According to the U.S. Census Bureau, about 112 million people in the U.S. had presbyopia in 2006. This number is expected to continue to increase in the next 10 years. Rise in prevalence of presbyopia, usage of contact lens, and emergence of novel ophthalmic technologies are likely to propel the presbyopia treatment market during the forecast period.

The global presbyopia treatment market can be segmented based on type of treatment, end-user, and region. In terms of type of treatment, the presbyopia treatment market can be classified into spectacle lenses, contact lenses, combination of contact & spectacle lenses, refractive surgery, drugs, and others. Based on end-user, the presbyopia market can be divided into hospitals, ophthalmic clinics, and ambulatory surgical centers. The hospitals segment accounted for the largest share of the global presbyopia treatment market in terms of revenue in 2017. The trend is expected to continue in the next few years. Increase in investments by key players in the development of effective distribution network with hospitals and creation of novel surgical platforms to meet the needs and demands of patients are likely to augment the hospitals segment during the forecast period.

In terms of region, the global presbyopia treatment market can be segmented into Europe, Asia Pacific, North America, Latin America, and Middle East & Africa. North America accounted for major share of the global presbyopia treatment market in 2017. Persistent rise in the geriatric population, increase in cases of presbyopia, and surge in awareness among people about the treatment of presbyopia drive the presbyopia treatment market in North America. The region is projected to sustain its position in the near future due to the advent of new technologies, rise in prevalence of ocular disorders and diseases, and increase in usage of latest technologies in corrective treatments for vision by ophthalmologists in North America.

Europe was the second most prominent market for presbyopia treatment in 2017 and the trend is expected to continue in the next few years. Rise in prevalence of presbyopia, increase in demand for minimally invasive surgeries, and favorable reimbursement policies are anticipated to propel the presbyopia treatment market in Europe during the forecast period.

The presbyopia treatment market in Asia Pacific is expected to witness strong growth in the near future. Rise in the geriatric population, increase in incidence of presbyopia, and surge in investments by key players to set up robust distribution channel can be attributed to the growth of presbyopia treatment market in the region. Rise in medical tourism and availability of low cost treatments are also projected to augment the presbyopia treatment market in Asia Pacific during the forecast period.

Request Brochure of the Report:

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=52689

Key players operating in the global presbyopia treatment market are Novartis AG, Allergan plc, ORASIS Pharmaceuticals Ltd., Abbott Laboratories, Inc., Bausch + Lomb Incorporated, Carl Zeiss, Inc., Nidek Co. Ltd., Lasersight Technologies, Inc., and Ziemer Ophthalmic Systems AG.